BioSpace News Archive

mRNA is synthesized in the nucleus with the use of a template made up of a DNA nucleotide sequence.

The peptide microarray market is expected to register a CAGR of 5% during the forecast period.

The growth of the personalized medicine biomarkers market is attributed to increasing demand and growing awareness about personalized medicine among healthcare professionals.

Industry Insights The global market for rare disease clinical trials is anticipated to register significant growth over the forecast period.

The global tele-epilepsy market was valued at USD 0.37 billion in 2021 and it is predicted to surpass around USD 1.2 billion by 2030 with a CAGR of 13.97% from 2022 to 2030.

Vulvovaginal Candidiasis (VVC) is one of the most common infections among women, affecting around 138 million women annually worldwide.

Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announces positive topline data from its phase 2 study evaluating safety, tolerability, and efficacy of imlifidase in reducing donor specific antibodies (DSAs) in patients with active and chronic active antibody mediated rejection (AMR) episodes.

The global In Vitro Diagnostics (IVD) market size was USD 98.00 Billion in 2021 and is expected to register a revenue CAGR of 2.3% during the forecast period.

The global bronchoscopy market size is expected to reach USD 3,174.0 Million in 2030 and register a revenue CAGR of 5.5% during the forecast period.

The global heparin market size was USD 6.76 Billion in 2020 and is expected to register a CAGR of 1.4% during the forecast period.